Healius Ltd Asset Resilience Ratio
Healius Ltd asset resilience ratio. Healius Ltd (HLS) has an Asset Resilience Ratio of 0.06% as of December 2015. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See HLS defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Healius Ltd (2002–2017)
Asset resilience ratio of Healius Ltd from 2002 to 2017. This chart shows how Healius Ltd's Asset Resilience Ratio has changed over time. Read Healius Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Healius Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Healius Ltd balance sheet assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$2.43 Million | 0.06% |
| Total Liquid Assets | AU$2.43 Million | 0.06% |
Asset Resilience Insights
- Limited Liquidity: Healius Ltd maintains only 0.06% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Healius Ltd Industry Peers by Asset Resilience Ratio
Compare Healius Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Voxel S.A.
WAR:VOX |
Diagnostics & Research | 0.32% |
|
Leveljump Healthcare Corp
V:JUMP |
Diagnostics & Research | 32.45% |
|
Prodia Widyahusada Tbk PT
JK:PRDA |
Diagnostics & Research | 7.82% |
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Integral Diagnostics Ltd
AU:IDX |
Diagnostics & Research | 0.03% |
|
Australian Clinical Labs Ltd
AU:ACL |
Diagnostics & Research | 4.11% |
|
Monash Ivf Group Ltd
AU:MVF |
Diagnostics & Research | 1.60% |
|
Cryosite Ltd
AU:CTE |
Diagnostics & Research | 5.65% |
Healius Ltd Asset Resilience Ratio by Year (2002–2017)
Healius Ltd asset resilience ratio by year from 2002 to 2017. The table below shows the annual Asset Resilience Ratio data for Healius Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2017-06-30 | 0.00% | AU$0.00 ≈ $0.00 |
AU$3.11 Billion ≈ $2.20 Billion |
-- |
| 2016-06-30 | 0.00% | AU$0.00 ≈ $0.00 |
AU$3.62 Billion ≈ $2.56 Billion |
-- |
| 2015-06-30 | 0.08% | AU$3.20 Million ≈ $2.26 Million |
AU$3.92 Billion ≈ $2.77 Billion |
-0.04pp |
| 2012-06-30 | 0.12% | AU$4.57 Million ≈ $3.24 Million |
AU$3.86 Billion ≈ $2.73 Billion |
+0.10pp |
| 2011-06-30 | 0.02% | AU$798.00K ≈ $564.64K |
AU$3.83 Billion ≈ $2.71 Billion |
-0.02pp |
| 2010-06-30 | 0.04% | AU$1.50 Million ≈ $1.06 Million |
AU$3.70 Billion ≈ $2.62 Billion |
-0.14pp |
| 2009-06-30 | 0.18% | AU$6.93 Million ≈ $4.91 Million |
AU$3.78 Billion ≈ $2.67 Billion |
+0.18pp |
| 2008-06-30 | 0.00% | AU$115.00K ≈ $81.37K |
AU$4.80 Billion ≈ $3.40 Billion |
-0.02pp |
| 2007-06-30 | 0.02% | AU$135.00K ≈ $95.52K |
AU$606.50 Million ≈ $429.14 Million |
+0.02pp |
| 2002-06-30 | 0.00% | AU$-6.00K ≈ $-4.25K |
AU$283.35 Million ≈ $200.49 Million |
-- |
About Healius Ltd
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patie… Read more